China Pharma Holdings Given OK for Generic Crestor® Trials

China Pharma Holdings obtained approval from the SFDA to begin Phase I and Phase II clinical trials of Rosuvastatin, a generic version of the cholesterol-lowering statin drug Crestor®. The trials will test the compound for efficacy. China Pharma will move to being the trials immediately with the goal of winning approval by the end of 2010. More details... Stock Symbol: (OTCBB: CPHI)